颗粒细胞殖民地刺激因子诱导的甜味综合征的临床特征,治疗和结果
Zhaoquan Wu1,2, Wei Sun3, Binsheng He1,2
1College of Pharmacy, Changsha Medical University, No. 1501 Leifeng Avenue, Xiangjiang New District, Changsha, 410219, Hunan, China.
Archives of dermatological research
|October 14, 2024
概括
甜味综合征 (SS) 是对粒细胞殖民地刺激因子 (G-CSF) 的罕见反应,表现为皮肤病变和发烧. 通过皮肤活检早期诊断和及时的皮质类固醇治疗是管理的关键.
科学领域:
- 皮肤病学 皮肤病学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 甜蜜综合征 (SS) 是一种与粒细胞殖民地刺激因子 (G-CSF) 相关的罕见不良反应.
- 由G-CSF引起的SS的特征需要进一步阐明,以有效预防和管理.
研究的目的:
- 为了描述G-CSF诱导的斯威特综合征.
- 为预防和管理G-CSF诱导的SS.提供指导.
主要方法:
- 对G-CSF诱导的SS病例报告的回顾性分析.
- 从相关数据库收集到2024年6月30日的数据.
主要成果:
- 分析了50名患者,中位数年龄为44岁;SS发病中位数为G-CSF后7天.
- 主要的症状:斑块/斑块 (74%),发烧 (74%). 皮肤活检显示中性粒细胞透 (97.8%).
- 在G-CSF停止和皮质类固醇治疗后7天内观察到症状改善.
结论:
- 在G-CSF治疗期间对SS的警对于临床医生至关重要.
- 皮肤活检对于诊断G-CSF诱导的SS非常重要.
- 由G-CSF诱导的SS对皮质类固醇反应良好;由于复发风险,应避免重新服用G-CSF.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Hypoglycemia and Glucagon
164
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
164


